NCI Digital Therapeutics Market Size, Share, Growth, and Industry Analysis, By Type (AD, AMCI), By Application (Medical Rehab Center, Hospitals, Geriatric Facilities, Nursing Homes, Others), Regional Insights and Forecast to 2035
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NCI Digital Therapeutics Market Size Growth Rate by Type: 2021 VS 2026 VS 2035
1.2.2 AD
1.2.3 AMCI
1.3 Market by Application
1.3.1 Global NCI Digital Therapeutics Market Growth by Application: 2021 VS 2026 VS 2035
1.3.2 Medical Rehab Center
1.3.3 Hospitals
1.3.4 Geriatric Facilities
1.3.5 Nursing Homes
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NCI Digital Therapeutics Market Perspective (2026-2035)
2.2 Global NCI Digital Therapeutics Growth Trends by Region
2.2.1 Global NCI Digital Therapeutics Market Size by Region: 2021 VS 2026 VS 2035
2.2.2 NCI Digital Therapeutics Historic Market Size by Region (2021-2026)
2.2.3 NCI Digital Therapeutics Forecasted Market Size by Region (2026-2035)
2.3 NCI Digital Therapeutics Market Dynamics
2.3.1 NCI Digital Therapeutics Industry Trends
2.3.2 NCI Digital Therapeutics Market Drivers
2.3.3 NCI Digital Therapeutics Market Challenges
2.3.4 NCI Digital Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NCI Digital Therapeutics Players by Revenue
3.1.1 Global Top NCI Digital Therapeutics Players by Revenue (2021-2026)
3.1.2 Global NCI Digital Therapeutics Revenue Market Share by Players (2021-2026)
3.2 Global Top NCI Digital Therapeutics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NCI Digital Therapeutics Revenue
3.4 Global NCI Digital Therapeutics Market Concentration Ratio
3.4.1 Global NCI Digital Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NCI Digital Therapeutics Revenue in 2026
3.5 Global Key Players of NCI Digital Therapeutics Head office and Area Served
3.6 Global Key Players of NCI Digital Therapeutics, Product and Application
3.7 Global Key Players of NCI Digital Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NCI Digital Therapeutics Breakdown Data by Type
4.1 Global NCI Digital Therapeutics Historic Market Size by Type (2021-2026)
4.2 Global NCI Digital Therapeutics Forecasted Market Size by Type (2026-2035)
5 NCI Digital Therapeutics Breakdown Data by Application
5.1 Global NCI Digital Therapeutics Historic Market Size by Application (2021-2026)
5.2 Global NCI Digital Therapeutics Forecasted Market Size by Application (2026-2035)
6 North America
6.1 North America NCI Digital Therapeutics Market Size (2026-2035)
6.2 North America NCI Digital Therapeutics Market Growth Rate by Country: 2021 VS 2026 VS 2035
6.3 North America NCI Digital Therapeutics Market Size by Country (2021-2026)
6.4 North America NCI Digital Therapeutics Market Size by Country (2026-2035)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NCI Digital Therapeutics Market Size (2026-2035)
7.2 Europe NCI Digital Therapeutics Market Growth Rate by Country: 2021 VS 2026 VS 2035
7.3 Europe NCI Digital Therapeutics Market Size by Country (2021-2026)
7.4 Europe NCI Digital Therapeutics Market Size by Country (2026-2035)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NCI Digital Therapeutics Market Size (2026-2035)
8.2 Asia-Pacific NCI Digital Therapeutics Market Growth Rate by Region: 2021 VS 2026 VS 2035
8.3 Asia-Pacific NCI Digital Therapeutics Market Size by Region (2021-2026)
8.4 Asia-Pacific NCI Digital Therapeutics Market Size by Region (2026-2035)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NCI Digital Therapeutics Market Size (2026-2035)
9.2 Latin America NCI Digital Therapeutics Market Growth Rate by Country: 2021 VS 2026 VS 2035
9.3 Latin America NCI Digital Therapeutics Market Size by Country (2021-2026)
9.4 Latin America NCI Digital Therapeutics Market Size by Country (2026-2035)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NCI Digital Therapeutics Market Size (2026-2035)
10.2 Middle East & Africa NCI Digital Therapeutics Market Growth Rate by Country: 2021 VS 2026 VS 2035
10.3 Middle East & Africa NCI Digital Therapeutics Market Size by Country (2021-2026)
10.4 Middle East & Africa NCI Digital Therapeutics Market Size by Country (2026-2035)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MindMaze Labs
11.1.1 MindMaze Labs Company Details
11.1.2 MindMaze Labs Business Overview
11.1.3 MindMaze Labs NCI Digital Therapeutics Introduction
11.1.4 MindMaze Labs Revenue in NCI Digital Therapeutics Business (2021-2026)
11.1.5 MindMaze Labs Recent Development
11.2 Akili
11.2.1 Akili Company Details
11.2.2 Akili Business Overview
11.2.3 Akili NCI Digital Therapeutics Introduction
11.2.4 Akili Revenue in NCI Digital Therapeutics Business (2021-2026)
11.2.5 Akili Recent Development
11.3 Cognoa
11.3.1 Cognoa Company Details
11.3.2 Cognoa Business Overview
11.3.3 Cognoa NCI Digital Therapeutics Introduction
11.3.4 Cognoa Revenue in NCI Digital Therapeutics Business (2021-2026)
11.3.5 Cognoa Recent Development
11.4 GrayMatters Health
11.4.1 GrayMatters Health Company Details
11.4.2 GrayMatters Health Business Overview
11.4.3 GrayMatters Health NCI Digital Therapeutics Introduction
11.4.4 GrayMatters Health Revenue in NCI Digital Therapeutics Business (2021-2026)
11.4.5 GrayMatters Health Recent Development
11.5 Otsuka Pharmaceutical
11.5.1 Otsuka Pharmaceutical Company Details
11.5.2 Otsuka Pharmaceutical Business Overview
11.5.3 Otsuka Pharmaceutical NCI Digital Therapeutics Introduction
11.5.4 Otsuka Pharmaceutical Revenue in NCI Digital Therapeutics Business (2021-2026)
11.5.5 Otsuka Pharmaceutical Recent Development
11.6 TALi Health
11.6.1 TALi Health Company Details
11.6.2 TALi Health Business Overview
11.6.3 TALi Health NCI Digital Therapeutics Introduction
11.6.4 TALi Health Revenue in NCI Digital Therapeutics Business (2021-2026)
11.6.5 TALi Health Recent Development
11.7 Dario Health
11.7.1 Dario Health Company Details
11.7.2 Dario Health Business Overview
11.7.3 Dario Health NCI Digital Therapeutics Introduction
11.7.4 Dario Health Revenue in NCI Digital Therapeutics Business (2021-2026)
11.7.5 Dario Health Recent Development
11.8 Better Therapeutics
11.8.1 Better Therapeutics Company Details
11.8.2 Better Therapeutics Business Overview
11.8.3 Better Therapeutics NCI Digital Therapeutics Introduction
11.8.4 Better Therapeutics Revenue in NCI Digital Therapeutics Business (2021-2026)
11.8.5 Better Therapeutics Recent Development
11.9 Nanjing Vishee Medical Technology
11.9.1 Nanjing Vishee Medical Technology Company Details
11.9.2 Nanjing Vishee Medical Technology Business Overview
11.9.3 Nanjing Vishee Medical Technology NCI Digital Therapeutics Introduction
11.9.4 Nanjing Vishee Medical Technology Revenue in NCI Digital Therapeutics Business (2021-2026)
11.9.5 Nanjing Vishee Medical Technology Recent Development
11.10 Zhejiang BrainAurora Medical Technology
11.10.1 Zhejiang BrainAurora Medical Technology Company Details
11.10.2 Zhejiang BrainAurora Medical Technology Business Overview
11.10.3 Zhejiang BrainAurora Medical Technology NCI Digital Therapeutics Introduction
11.10.4 Zhejiang BrainAurora Medical Technology Revenue in NCI Digital Therapeutics Business (2021-2026)
11.10.5 Zhejiang BrainAurora Medical Technology Recent Development
11.11 Hunan Mental Health Medicine Technology
11.11.1 Hunan Mental Health Medicine Technology Company Details
11.11.2 Hunan Mental Health Medicine Technology Business Overview
11.11.3 Hunan Mental Health Medicine Technology NCI Digital Therapeutics Introduction
11.11.4 Hunan Mental Health Medicine Technology Revenue in NCI Digital Therapeutics Business (2021-2026)
11.11.5 Hunan Mental Health Medicine Technology Recent Development
11.12 Hunan Aize Medical Technology
11.12.1 Hunan Aize Medical Technology Company Details
11.12.2 Hunan Aize Medical Technology Business Overview
11.12.3 Hunan Aize Medical Technology NCI Digital Therapeutics Introduction
11.12.4 Hunan Aize Medical Technology Revenue in NCI Digital Therapeutics Business (2021-2026)
11.12.5 Hunan Aize Medical Technology Recent Development
11.13 Qingdao Zhisong Technology
11.13.1 Qingdao Zhisong Technology Company Details
11.13.2 Qingdao Zhisong Technology Business Overview
11.13.3 Qingdao Zhisong Technology NCI Digital Therapeutics Introduction
11.13.4 Qingdao Zhisong Technology Revenue in NCI Digital Therapeutics Business (2021-2026)
11.13.5 Qingdao Zhisong Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NCI Digital Therapeutics Market Size Growth Rate by Type: 2021 VS 2026 VS 2035
1.2.2 AD
1.2.3 AMCI
1.3 Market by Application
1.3.1 Global NCI Digital Therapeutics Market Growth by Application: 2021 VS 2026 VS 2035
1.3.2 Medical Rehab Center
1.3.3 Hospitals
1.3.4 Geriatric Facilities
1.3.5 Nursing Homes
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NCI Digital Therapeutics Market Perspective (2026-2035)
2.2 Global NCI Digital Therapeutics Growth Trends by Region
2.2.1 Global NCI Digital Therapeutics Market Size by Region: 2021 VS 2026 VS 2035
2.2.2 NCI Digital Therapeutics Historic Market Size by Region (2021-2026)
2.2.3 NCI Digital Therapeutics Forecasted Market Size by Region (2026-2035)
2.3 NCI Digital Therapeutics Market Dynamics
2.3.1 NCI Digital Therapeutics Industry Trends
2.3.2 NCI Digital Therapeutics Market Drivers
2.3.3 NCI Digital Therapeutics Market Challenges
2.3.4 NCI Digital Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NCI Digital Therapeutics Players by Revenue
3.1.1 Global Top NCI Digital Therapeutics Players by Revenue (2021-2026)
3.1.2 Global NCI Digital Therapeutics Revenue Market Share by Players (2021-2026)
3.2 Global Top NCI Digital Therapeutics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NCI Digital Therapeutics Revenue
3.4 Global NCI Digital Therapeutics Market Concentration Ratio
3.4.1 Global NCI Digital Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NCI Digital Therapeutics Revenue in 2026
3.5 Global Key Players of NCI Digital Therapeutics Head office and Area Served
3.6 Global Key Players of NCI Digital Therapeutics, Product and Application
3.7 Global Key Players of NCI Digital Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NCI Digital Therapeutics Breakdown Data by Type
4.1 Global NCI Digital Therapeutics Historic Market Size by Type (2021-2026)
4.2 Global NCI Digital Therapeutics Forecasted Market Size by Type (2026-2035)
5 NCI Digital Therapeutics Breakdown Data by Application
5.1 Global NCI Digital Therapeutics Historic Market Size by Application (2021-2026)
5.2 Global NCI Digital Therapeutics Forecasted Market Size by Application (2026-2035)
6 North America
6.1 North America NCI Digital Therapeutics Market Size (2026-2035)
6.2 North America NCI Digital Therapeutics Market Growth Rate by Country: 2021 VS 2026 VS 2035
6.3 North America NCI Digital Therapeutics Market Size by Country (2021-2026)
6.4 North America NCI Digital Therapeutics Market Size by Country (2026-2035)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NCI Digital Therapeutics Market Size (2026-2035)
7.2 Europe NCI Digital Therapeutics Market Growth Rate by Country: 2021 VS 2026 VS 2035
7.3 Europe NCI Digital Therapeutics Market Size by Country (2021-2026)
7.4 Europe NCI Digital Therapeutics Market Size by Country (2026-2035)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NCI Digital Therapeutics Market Size (2026-2035)
8.2 Asia-Pacific NCI Digital Therapeutics Market Growth Rate by Region: 2021 VS 2026 VS 2035
8.3 Asia-Pacific NCI Digital Therapeutics Market Size by Region (2021-2026)
8.4 Asia-Pacific NCI Digital Therapeutics Market Size by Region (2026-2035)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NCI Digital Therapeutics Market Size (2026-2035)
9.2 Latin America NCI Digital Therapeutics Market Growth Rate by Country: 2021 VS 2026 VS 2035
9.3 Latin America NCI Digital Therapeutics Market Size by Country (2021-2026)
9.4 Latin America NCI Digital Therapeutics Market Size by Country (2026-2035)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NCI Digital Therapeutics Market Size (2026-2035)
10.2 Middle East & Africa NCI Digital Therapeutics Market Growth Rate by Country: 2021 VS 2026 VS 2035
10.3 Middle East & Africa NCI Digital Therapeutics Market Size by Country (2021-2026)
10.4 Middle East & Africa NCI Digital Therapeutics Market Size by Country (2026-2035)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MindMaze Labs
11.1.1 MindMaze Labs Company Details
11.1.2 MindMaze Labs Business Overview
11.1.3 MindMaze Labs NCI Digital Therapeutics Introduction
11.1.4 MindMaze Labs Revenue in NCI Digital Therapeutics Business (2021-2026)
11.1.5 MindMaze Labs Recent Development
11.2 Akili
11.2.1 Akili Company Details
11.2.2 Akili Business Overview
11.2.3 Akili NCI Digital Therapeutics Introduction
11.2.4 Akili Revenue in NCI Digital Therapeutics Business (2021-2026)
11.2.5 Akili Recent Development
11.3 Cognoa
11.3.1 Cognoa Company Details
11.3.2 Cognoa Business Overview
11.3.3 Cognoa NCI Digital Therapeutics Introduction
11.3.4 Cognoa Revenue in NCI Digital Therapeutics Business (2021-2026)
11.3.5 Cognoa Recent Development
11.4 GrayMatters Health
11.4.1 GrayMatters Health Company Details
11.4.2 GrayMatters Health Business Overview
11.4.3 GrayMatters Health NCI Digital Therapeutics Introduction
11.4.4 GrayMatters Health Revenue in NCI Digital Therapeutics Business (2021-2026)
11.4.5 GrayMatters Health Recent Development
11.5 Otsuka Pharmaceutical
11.5.1 Otsuka Pharmaceutical Company Details
11.5.2 Otsuka Pharmaceutical Business Overview
11.5.3 Otsuka Pharmaceutical NCI Digital Therapeutics Introduction
11.5.4 Otsuka Pharmaceutical Revenue in NCI Digital Therapeutics Business (2021-2026)
11.5.5 Otsuka Pharmaceutical Recent Development
11.6 TALi Health
11.6.1 TALi Health Company Details
11.6.2 TALi Health Business Overview
11.6.3 TALi Health NCI Digital Therapeutics Introduction
11.6.4 TALi Health Revenue in NCI Digital Therapeutics Business (2021-2026)
11.6.5 TALi Health Recent Development
11.7 Dario Health
11.7.1 Dario Health Company Details
11.7.2 Dario Health Business Overview
11.7.3 Dario Health NCI Digital Therapeutics Introduction
11.7.4 Dario Health Revenue in NCI Digital Therapeutics Business (2021-2026)
11.7.5 Dario Health Recent Development
11.8 Better Therapeutics
11.8.1 Better Therapeutics Company Details
11.8.2 Better Therapeutics Business Overview
11.8.3 Better Therapeutics NCI Digital Therapeutics Introduction
11.8.4 Better Therapeutics Revenue in NCI Digital Therapeutics Business (2021-2026)
11.8.5 Better Therapeutics Recent Development
11.9 Nanjing Vishee Medical Technology
11.9.1 Nanjing Vishee Medical Technology Company Details
11.9.2 Nanjing Vishee Medical Technology Business Overview
11.9.3 Nanjing Vishee Medical Technology NCI Digital Therapeutics Introduction
11.9.4 Nanjing Vishee Medical Technology Revenue in NCI Digital Therapeutics Business (2021-2026)
11.9.5 Nanjing Vishee Medical Technology Recent Development
11.10 Zhejiang BrainAurora Medical Technology
11.10.1 Zhejiang BrainAurora Medical Technology Company Details
11.10.2 Zhejiang BrainAurora Medical Technology Business Overview
11.10.3 Zhejiang BrainAurora Medical Technology NCI Digital Therapeutics Introduction
11.10.4 Zhejiang BrainAurora Medical Technology Revenue in NCI Digital Therapeutics Business (2021-2026)
11.10.5 Zhejiang BrainAurora Medical Technology Recent Development
11.11 Hunan Mental Health Medicine Technology
11.11.1 Hunan Mental Health Medicine Technology Company Details
11.11.2 Hunan Mental Health Medicine Technology Business Overview
11.11.3 Hunan Mental Health Medicine Technology NCI Digital Therapeutics Introduction
11.11.4 Hunan Mental Health Medicine Technology Revenue in NCI Digital Therapeutics Business (2021-2026)
11.11.5 Hunan Mental Health Medicine Technology Recent Development
11.12 Hunan Aize Medical Technology
11.12.1 Hunan Aize Medical Technology Company Details
11.12.2 Hunan Aize Medical Technology Business Overview
11.12.3 Hunan Aize Medical Technology NCI Digital Therapeutics Introduction
11.12.4 Hunan Aize Medical Technology Revenue in NCI Digital Therapeutics Business (2021-2026)
11.12.5 Hunan Aize Medical Technology Recent Development
11.13 Qingdao Zhisong Technology
11.13.1 Qingdao Zhisong Technology Company Details
11.13.2 Qingdao Zhisong Technology Business Overview
11.13.3 Qingdao Zhisong Technology NCI Digital Therapeutics Introduction
11.13.4 Qingdao Zhisong Technology Revenue in NCI Digital Therapeutics Business (2021-2026)
11.13.5 Qingdao Zhisong Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer






